Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ketamine vs Dexmedetomidine in Endoscopic Nasal Surgeries
NCT07056582Recruiting
- Sponsor
- Sohag University
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in postoperative pain comparing Dexmedetomidine, Ketamine and Placebo (3 arms). Primary endpoint: Efficacy of nebulized dexmedetomidine vs nebulized ketamine to achieve good postoperative pain management at 24 hours. Started Apr 2025; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07056582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07056582.